Canadian medical reactor gets nod to restart

Jul 07, 2010

Canada's nuclear safety commission authorized Wednesday the restarting of a reactor that produced one-third of the world's supply of medical isotopes before it closed for repairs last year.

The half-century old National Research Universal reactor in Chalk River, Ontario, 185 kilometers (115 miles) northwest of Ottawa, could be restarted at the end of the month.

It was shut down in May 2009 after a leak of inside the reactor.

Atomic Energy of Canada Limited (AECL) had initially estimated the stoppage would last only a few months.

produced by the are used to diagnose cancer and heart disease in patients around the world. The shutdown led to a global shortage of the precious radioactive material.

Explore further: Simulation-based training improves endoscopy execution

add to favorites email to friend print save as pdf

Related Stories

Rebooting of Canadian medical isotope reactor delayed

Aug 13, 2009

A Canadian reactor that produced one-third of the world's supply of medical isotopes before it closed in May for repairs will remain offline at least until early 2010, nuclear authorities said Thursday.

A top supplier of medical isotopes closed through 2009

Jul 08, 2009

An aging Canadian nuclear reactor responsible for production of one-third of the isotopes used in medical radiation treatment around the world will be out of service through at least the end of 2009, authorities said Wednesday.

Officials seek cause of reactor shutdown

Nov 03, 2006

Authorities are investigating the cause of the nuclear reactor shutdown at Three Mile Island near Harrisburg, Pa., although no radiation leaked in the incident.

Recommended for you

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0